New ways to prevent non-melanoma skin cancer
Targeted Prevention for Non-Melanoma Skin Cancer
This study is looking for new ways to help prevent non-melanoma skin cancers, like basal cell and squamous cell carcinoma, by understanding how these cancers develop and testing new treatments that could lower your risk.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10686365 on NIH RePORTER |
What this research studies
This research focuses on developing targeted prevention strategies for non-melanoma skin cancer, which includes basal cell carcinoma and squamous cell carcinoma. The project aims to understand the biological pathways involved in skin cancer development and to create new drugs that can prevent these cancers from forming. By using experimental models and human studies, the researchers will explore how specific molecular targets can be effectively modulated to reduce the risk of skin cancer. Patients may benefit from innovative treatments that could significantly lower their chances of developing these common skin cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for non-melanoma skin cancer, such as those with a history of skin lesions or significant sun exposure.
Not a fit: Patients who have already been diagnosed with advanced non-melanoma skin cancer may not benefit from this preventive research.
Why it matters
Potential benefit: If successful, this research could lead to effective prevention strategies that significantly reduce the incidence of non-melanoma skin cancer.
How similar studies have performed: Previous research has shown promise in targeting specific molecular pathways for cancer prevention, indicating that this approach could be effective.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Curiel-Lewandrowski, Clara — University of Arizona
- Study coordinator: Curiel-Lewandrowski, Clara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.